Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06522334

Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Ludwig Boltzmann Institute for Lung Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death. There are no additional interventions regarding this registry.

Conditions

Timeline

Start date
2024-02-28
Primary completion
2034-02-28
Completion
2034-02-28
First posted
2024-07-26
Last updated
2025-03-14

Locations

5 sites across 1 country: Austria

Source: ClinicalTrials.gov record NCT06522334. Inclusion in this directory is not an endorsement.